drugset
drugset / Trial / NCT04489628

Tele-health Enabled Clinical Trial for COVID-19

NCT04489628 ↗

Phase 1/2 Withdrawn University Hospitals Cleveland Medical Center Northwestern University · collab
RandomizedParallel-groupTriple-blindTreatment

Summary

To determine the efficacy of high dose Vitamin D (an over-the-counter nutritional supplement) in preventing immune-related complications in outpatients with confirmed SARS-CoV-2 infection.

Timeline

Start
2020-08-01
Primary completion
2021-06-01
Completion
2021-06-01

Drugs

EvaluationDrugModalityDoseRoute
Comparator Cholecalciferol Other / unclassified 50000 iu —

Indications

COVID-19